Mayo Clinic’s Scilex Holding SCLX Stock Holding History

Mayo Clinic’s Portfolio SCLX Stock Details SCLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,209	Closed	-$86.3K	–	8
2023 Q4	$86.3K	Hold	1,209	–	–	0.53%	6
2023 Q3	$59.2K	Hold	1,209	–	–	0.11%	9
2023 Q2	$236K	Hold	1,209	–	–	0.24%	8
2023 Q1	$347K	Buy	+1,209	New	+$335K	0.28%	5

Other funds holding SCLX

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mayo Clinic's SCLX Position: Q1 2024 in Review

Mayo Clinic sold out of Scilex Holding (SCLX) in Q1 2024, closing a stake of 1,209 shares — an estimated $86.3K sold.

Mayo Clinic first reported a position in SCLX in Q1 2023 and held it in 4 quarters. The position peaked at $347K in Q1 2023. 95 funds tracked by Wall St. Rank hold SCLX as of Q1 2024.

Mayo Clinic reported no remaining Scilex Holding position as of Q1 2024 after selling out during the quarter.
Mayo Clinic sold 1,209 Scilex Holding shares in Q1 2024, an estimated $86.3K.
Mayo Clinic first reported a position in Scilex Holding in Q1 2023 and held it in 4 quarters.
Mayo Clinic's Scilex Holding position peaked at $347K in Q1 2023.
95 funds tracked by Wall St. Rank held Scilex Holding as of Q1 2024.

Based on Mayo Clinic's 13F filing for Q1 2024, filed 13 May 2024.